文献速递胸部外周血管CTDSA

BMPR2突变相关肺动脉高压的影像学特征

Imaging Features in BMPR2 Mutation-associated Pulmonary Arterial Hypertension.
PubMed 文献 · Radiology · 2023-05-16

回顾性研究纳入82例BMPR2突变肺动脉高压患者和193例无突变患者,评估CT和肺动脉造影特征。BMPR2突变患者更常见血管周围晕和新生血管,肺动脉造影可见「霜晶」征,提示基因与肺血管及全身表现相关。

要点

  • BMPR2突变患者CT上血管周围晕和新生血管更常见,重度者常共存。
  • 肺动脉造影「霜晶」征在BMPR2突变者中更频繁(53% vs 12%)。
  • 识别血管周围晕和新生血管有助提示BMPR2突变相关PAH。

核心结论

  • BMPR2突变PAH患者在CT上显示血管周围晕和新生血管等特征,提示基因、肺及全身表现之间存在联系。

研究设计与样本

  • 回顾性研究,纳入2010年1月至2021年12月诊断IPAH或HPAH患者275例(BMPR2突变82例,无突变193例),评估胸部CT、肺动脉造影及基因检测数据,由四名独立阅片者按四级严重程度评分。

关键影像表现/征象

  • CT可见血管周围晕、新生血管、小叶中心磨玻璃影和全小叶磨玻璃影,按四级严重程度评分。
  • 血管周围晕在BMPR2突变组38%(31/82) vs 无突变组13%(25/193),P < .001。
  • 新生血管在BMPR2突变组60%(49/82) vs 无突变组34%(66/193),P < .001。
  • 肺动脉造影「霜晶」征在BMPR2突变组53%(10/19) vs 无突变组12%(4/34),P < .01。
  • BMPR2突变患者中重度血管周围晕常与重度新生血管共存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Germline mutation in the BMPR2 gene is common in patients with pulmonary arterial hypertension (PAH). However, its association with imaging findings in these patients is, to the knowledge of the authors, unknown. Purpose To characterize distinctive pulmonary vascular abnormalities at CT and pulmonary artery angiography in patients with and without BMPR2 mutation. Materials and Methods In this retrospective study, chest CT scans, pulmonary artery angiograms, and genetic test data were acquired for patients diagnosed with idiopathic PAH (IPAH) or heritable PAH (HPAH) between January 2010 and December 2021. Perivascular halo, neovascularity, centrilobular ground-glass opacity (GGO), and panlobular GGO were evaluated at CT and graded on a four-point severity scale by four independent readers. Clinical characteristics and imaging features between patients with BMPR2 mutation and noncarriers were analyzed using the Kendall rank-order coefficient and the Kruskal-Wallis test. Results This study included 82 patients with BMPR2 mutation (mean age, 38 years ± 15 [SD]; 34 men; 72 patients with IPAH and 10 patients with HPAH) and 193 patients without the mutation, all with IPAH (mean age, 41 years ± 15; 53 men). A total of 115 patients (42%; 115 of 275) had neovascularity, and 56 patients (20%; 56 of 275) had perivascular halo at CT, and so-called frost crystals were observed on pulmonary artery angiograms in 14 of 53 (26%) patients. Compared with patients without BMPR2 mutation, patients with BMPR2 mutation more frequently showed two distinctive radiographic manifestations, perivascular halo and neovascularity (38% [31 of 82] vs 13% [25 of 193] in perivascular halo [P < .001] and 60% [49 of 82] vs 34% [66 of 193] in neovascularity [P < .001], respectively). "Frost crystals" were more frequent in patients with BMPR2 mutation compared with noncarriers (53% [10 of 19] vs 12% [four of 34]; P < .01). Severe perivascular halo frequently coexisted with severe neovascularity in patients with BMPR2 mutation. Conclusion Patients with PAH with BMPR2 mutation showed distinctive features at CT, specifically perivascular halo and neovascularity. This suggested a link between the genetic, pulmonary, and systemic manifestations that underly the pathogenesis of PAH. © RSNA, 2023 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Zhao, Zhang, Shi, et al. Imaging Features in BMPR2 Mutation-associated Pulmonary Arterial Hypertension. Radiology. 2023. PMID: 37191488. doi:10.1148/radiol.222488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。